Literature DB >> 9845792

Pharmacokinetics in organs and the intact body: model validation and reduction.

M Weiss1.   

Abstract

Physiological pharmacokinetic models are based on the structure of the circulatory system reflecting the convective transport of drug by blood flow to the various organs and tissues. Distribution kinetics at the organ level is mostly simplified as transfer between well-stirred compartments neglecting a priori the effects of intravascular dispersion and diffusion within tissue parenchyma. Recirculatory models based on residence time theory overcome these structural limitations since they allow in a most general way the decomposition of the body into its natural subsystems. Because of the unidentifiability of the global multi-organ model on the basis of plasma concentration-time curves the following methods/experimental designs will be discussed which provide quantitative information regarding the subsystems under in vivo conditions: (i) determination of tissue concentration-time profiles (destructive sampling), (ii) estimation of the organ transit time density from input/output profiles and (iii) application of a recirculatory model with reduced complexity to clinical pharmacokinetic data.

Mesh:

Year:  1999        PMID: 9845792     DOI: 10.1016/s0928-0987(98)00014-1

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trapping.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

Review 3.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

5.  Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research.

Authors:  Marianthi G Lerapetritou; Panos G Georgopoulos; Charles M Roth; Loannis P Androulakis
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

6.  Kinetic analysis of saturable myocardial uptake of idarubicin in rat heart: effect of doxorubicin and hypothermia.

Authors:  Wonku Kang; Michael Weiss
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

Review 7.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

8.  Physiologically based structure of mean residence time.

Authors:  Mária Durišová
Journal:  ScientificWorldJournal       Date:  2012-04-01

Review 9.  Towards wearable and implantable continuous drug monitoring: A review.

Authors:  Sumin Bian; Bowen Zhu; Guoguang Rong; Mohamad Sawan
Journal:  J Pharm Anal       Date:  2020-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.